Informatie:
Fout:
ID
29249
Beschrijving
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00982644
Link
https://clinicaltrials.gov/show/NCT00982644
Trefwoorden
Versies (1)
- 11-03-18 11-03-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
11 maart 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes NCT00982644
Eligibility Diabetes NCT00982644
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT00982644
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Antidiabetics Oral Dose unchanged
Item
treatment with oral antidiabetic drugs (oads) for at least three months before trial start at an unchanged dose
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0442739 (UMLS CUI [1,4])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0442739 (UMLS CUI [1,4])
Glucohemoglobin measurement
Item
hba1c: 7.0-10.0%
boolean
C0202054 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) no higher than 40.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Period Extension | Therapeutic procedure Period Completion
Item
for the extension trial only: completion of the 52 week treatment period in trial nn1250-3579 (nct00982644)
boolean
C2347804 (UMLS CUI [1,1])
C0231448 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C2347804 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C0231448 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C2347804 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
exenatide | liraglutide
Item
treatment with exenatide or liraglutide within the last 3 months before trial start
boolean
C0167117 (UMLS CUI [1])
C1456408 (UMLS CUI [2])
C1456408 (UMLS CUI [2])
Cardiovascular Disease
Item
cardiovascular disease within the last 6 months
boolean
C0007222 (UMLS CUI [1])
Severe Hypertension Uncontrolled Treated | Severe Hypertension Uncontrolled untreated
Item
uncontrolled treated/untreated severe hypertension
boolean
C4013784 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C4013784 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,3])
C0205318 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C4013784 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,3])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent
Item
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Malignant Neoplasms
Item
cancer and medical history of cancer
boolean
C0006826 (UMLS CUI [1])